Radioembolization in the Treatment of Metastatic Liver Cancer
Journal Title: Nükleer Tıp Seminerleri - Year 2019, Vol 5, Issue 2
Abstract
Transarterial radioembolization is an important alternative for treatment of primary liver tumors and metastatic liver disease. While initial indication of radioembolization was the last step in unresectable tumors refractory to chemotherapy, recently, it is also used in addition to chemotherapy or to decrease tumor size before surgery. Ongoing clinical studies target comparing the success rates of this local therapy with traditional systemic therapies or transarterial chemoembolization as the first-line therapy. In this section, clinical results of transarterial radioembolization in metastatic liver tumors based on the literature and targeted indications of use will be mentioned.
Authors and Affiliations
Nuriye Özlem Küçük, Pınar Akkuş
Positron Emission Tomography/Magnetic Resonance Imaging Practices in Oncological Imaging
Biomedical imaging plays an increasingly important role in primary staging, biopsy guidance, prognostic assessment, selection of treatment protocol, monitoring of treatment response and assessment of recurrent disease in...
Nuclear Cardiology in Heart Failure and Arrhythmias
As a result of improvement in radionuclide imaging modalities, the modulation of functional and electrophysiological characteristics of the heart by the autonomic nervous system has been the focus of cardiovascular resea...
Breast Cancer Models
Breast cancer is the most common cancer in women. 11.5% of breast cancer patients are at distant stage and mortality is due to metastases rather than primary disease. Experimental breast cancer tumor models are validated...
Nuclear Cardiology in Asymptomatic Patients
One of the most important causes of death is still myocardial ischemia which is caused by myocardial oxygen demand not supplied by coronary blood flow due to coronary artery disease in increased workload conditions. Stab...
Advances in Nuclear Cardiology: Instrumentation, Software and Radiopharmaceuticals
Progress in equipment and software technology in nuclear medicine has contributed substantially to cardiac imaging. The most notable consequences of this progress are improvement in image quality and reduction in acquisi...